We describe two new methods for the separation and quantification of the bone and liver isoenzymes of alkaline phosphatase (EC 3.1.3.1) in plasma. In the first, we use wheat-germ lectin to precipitate the bone isoenzyme. About 80% of this, but minimal liver isoenzyme, is precipitated. The activity of the bone isoenzyme is calculated from measuring the alkaline phosphatase activity in the precipitate, that of liver alkaline phosphatase by subtracting the activity of the bone isoenzyme from total alkaline phosphatase activity. The liver fraction will also contain biliary, intestinal, and placental alkaline phosphatase if these are present in the original plasma, but correction for such activity is readily made. In the second method, samples are separated on cellulose acetate membranes that, before electrophoresis, have been soaked in buffer containing wheat-germ lectin. The bone isoenzyme is retarded and clearly separated from the liver fraction, allowing these isoenzymes to be quantified by densitometry. Both methods are rapid, reproducible, and suitable for use in the diagnostic laboratory. germ on the plasma isoenzymes of alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum) EC 3.1.3.1; ALP], with the bone form being preferentially bound. We describe here the use of this lectin in a precipitation procedure and an aflinity electrophoresis method for the quantification of the bone and liver ALP fractions of human plasma.
Lectinsare highly specific, carbohydrate-binding proteins ofplant origin. Many attempts have been made to utilize them forisoenzyme differentiation, but generallyhave not resulted in diagnostically useful procedures. At the suggestion of Professor Joachim Kohn we re-examined the effect of lectins on various isoenzyme systems. During our studies we observed a marked differential effect of lectin from wheat (Triticum   vulgaris) germ on the plasma isoenzymes of alkaline phosphatase [orthophosphoric-monoester phosphohydrolase (alkaline optimum) EC 3.1.3.1; ALP], with the bone form being preferentially bound. We describe here the use of this lectin in a precipitation procedure and an aflinity electrophoresis method for the quantification of the bone and liver ALP fractions of human plasma.
Materials and Methods

Clinical Specimens
We collected blood into tubes containing lithium heparmn (Sterilin Ltd., Hampshire, U.K.; 15 mt. units of heparin per milliliter of blood), and obtained the plasma by centrifugation. To evaluate the precipitation procedure, we examined plasma samples from 67 healthy student volunteers (40 men, 27 women) ages 20 to 36 years; 39 patients with clinically suspected liver disease, who had increased activities of plasma ALP and aspartate aminotransferase (EC 2.6.1.1); 27 patients with suspected bone disease who had increased activities of plasma ALP but normal aspartate
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aminotransferase; 20 children hospitalizedfor minor infections; and 20 women in the last trimester of pregnancy. For the affinity electrophoresis method, we examined plasma samples from 66 of the healthy volunteers and from 44 of the patients with bone or liver disease. Plasma was stored in aliquots at -18 #{176}C and examined within one month of collection. Samples were thawed by standing overnight at 4#{176}C before assay.
Measurement of Total ALP
We determined total ALP activity at 30#{176}C using 4-nitrophenyl phosphate substrate and diethanolanune buffer accordingto the Associationof Clinical Biochemists Proposed Method (1) adapted for a discrete analyzer, the ABA
Bichromatic
Analyzer (Abbott Laboratories, Dallas, TX). In our laboratory the upper normal reference limit for adults is 205 U/L. and magnesium sulfate, 1 mmolfL, in a 10 g/L agar gel (Agar-Noble; Difco Laboratories, West Surrey, U.K.). The stained membrane was then soaked for 5 mm in aqueous acetic acid (50 mLIL), washed with distilled water, and dried between weighted-down filter paper. In samples containing intestinal orbiliary isoenzymesofALP, we quantified these isoenzymes by scanning the stained membrane with a densitometer (Model 720; Corning Medical, Medfleld, MA).
Measurement of ALP Isoenzymes
Sequential heat-inactivation:
We also quantified liver and bone ALP activities by sequential heat-inactivation (3), heatingthe sample at 57 #{176}C for 15 and 25 mm. Loss of ALP activity over this period is assumed to be linear and due entirely to liver ALP, sothat bone ALP is calculated as total ALP minus the liver fraction.
Lectin precipitation:
We prepared in distilled water a 5 g/L (139 .tmoIfL) aqueous solution of wheat-germ lectin, available as a lyophilized powder from Sigma Chemical Co. or Boehringer Mannheim, Mannheim, F.R.G. To determine ALP isoenzymes, we mixed 50 jL of the lectin solution with 50 L of plasma. Samples demonstrated by preliminary electrophoresis to contain biliary ALP were pretreated by incubating, for 30 mm at 37 #{176}C, 50 &L of sample with 5 L of Triton X-100 surfactant (BDH Chemicals Ltd., Dagenham, Essex, U.K.), 20 g/L in distilled water. The lectislplasma mixture was incubated for 30 mm at 37 #{176}C and centrifuged (2000 x g) for 15 mm. We removed all of the supernate by aspiration with a fine-bore pipette and measured its ALP activity. We resuspended the precipitate in 100 tL of saline (sodium chloride, 154 mmolJL of distilled water) and determined its ALP activity. Alternatively, the precipitate may be solubilized in 100 L of sodium dodecyl sulfate (BDH Chemicals Ltd.), 35 mmol/L in saline solution. Combining the precipitate and supernate activities, and adjusting for sample dilution, yields the total recovery of isoenzyme activity.
About 80% of the bone ALP in plasma is precipitated, whereas precipitation of liver ALP is minimal (see Results). We therefore calculated the bone ALP content of the plasma sample by multiplying the ALP activity of the resuspended or solubilized precipitate by 1.25 (100/80) and adjusting for the initial sample dilution. Subtracting bone ALP from the total ALP activity yields the ALP activity of liver origin (plus biliary, intestinal, and placental ALP when these are present in the original sample). Biliary and intestinal ALP may be identified by preliminary electrophoresis with the conventional method described above (detection limit 5-10 U/L); if their presence is clearly visible, their activity may be quantified by densitometry (4) and deducted from the total ALP activity before calculating the liver ALP activity. Placental ALP, which appears in plasma during late pregnancy, can be determined as the activity remaining in the original sample afterheating at 65 #{176}C for 5 mm (5).
Affinity electrophoresis: The electrophoretic procedure described above for separation of ALP isoenzymeswas modified by including wheat-germ lectin, 50 mg/L (1.39 prnol/L), in the buffer used to soak the cellulose acetate membrane before electrophoresis.
We quantified the bone and liver isoenzymes by reflectancedensitometry at 600 nm, and expressed the results as percentages of totalALP activity. The activity of each isoenzyme fraction was calculated by multiplying the percentage by the totalALP activity.
Results
Precipitation Procedure
Optimization studies: Optimal conditions for the precipitation method were established from measurements of ALP activity in the precipitate and supernate after lectin treatment. Results were identical for either serum or plasma from the same blood sample and for either resuspended precipitates or those solubilized in sodium dodecyl sulfate. We investigated varying the lectin concentrations between 1.25 and 10 gIL, in either distilled water or saline; incubation times between 5 and 30 mm and temperatures between 20 and 37 #{176}C; and addition of polyethylene glycol 6000 (BDH Chemicals Ltd.) up to a finalconcentration of 20 g/L. The conditions detailed above yielded maximal differentiation between plasma samples from patients with bone and liver disease, which had been shown by electrophoresis to contain predominantly bone or liver ALP, respectively.
Composition of precipitates and supernates from lectintreated plasma:
Butanol or aqueous extracts of bone and liver ALP were less effectively differentiated by wheat-germ lectin than were patients' plasma samples containing these respective isoenzymes, presumably because of alteration in surface carbohydrate during extraction, or because of mati-ix effects. Thus we quantified the extent of precipitation of the bone and liver fractions from plasma by the lectin by comparison with the results of the sequential heat-inactivation method. For the comparison, we used 14 plasma samples shown by electrophoresis and by sequentialheatinactivation tocontainmainly bone ALP and seven samples that contained mainly liver ALP.
For plasma samples for which 90 ± 7.9% (mean ± SD) of the total activity was bone ALP (by heat-inactivation method), 73 ± 11% of total ALP was precipitated by lectin, whereas for samples with a mean bone ALP of 25 ± 5.4% (heat inactivation) only 21 ± 6.0% of total ALP was precipitated. Extrapolation of these data indicates that, on the average, 80% of bone ALP would be precipitated from plasmas composed entirely of this isoenzyme, whereas the precipitate from plasma containing entirely liver enzyme would show negligible ALP activity. Activity in the precipitates of mixtures of plasma containing the bone and liver isoenzymes in various proportions demonstrated that a constant proportion of bone ALP was precipitated in each case. We concluded that it was appropriate to multiply the precipitate activity by 1.25 to determine the activity of bone ALP in the original sample.
Analytical recovery of total ALP activity from precipitates and supernates combined was 103% for the group of samples containing bone ALP and 110% in the liver ALP group. This indicates some activation of ALP activity, most markedly in the samples containing the highest proportion of the liver fraction.
We further examined the ALP isoenzyme composition of the precipitates and supernates by electrophoresis. To do so, we eluted ALP from the precipitates by adding 100 pL of Nacetylglucosamine (Sigma Chemical Co.), 45 minollL in saline solution. Wheat-germ lectin is known to bind to Nacetylglucosamine residues of glycoproteins (6), and we found that the precipitated bone ALP from plasma was fully unbound and solubilized by this concentration of N-acetylglucosamine.
In plasmas with undetectable bone ALP in the original sample we saw none of this isoenzyme in the supernate or the precipitate afterlectin treatment. However, in plasmas thought to contain mainly bone ALP some liver ALP was generally detectable in the supernate after lectin treatment, together with some activity at the origin on the electrophoretogram, presumably from bound but unprecipitated bone enzyme. Only bone ALP was recoverable from the lectin precipitates at activities averaging 83% oftotal ALP in the three samples examined.
For patients with liver disease, whose plasmas were shown by electrophoresis to contain solely liver and biliary ALP, the lectin treatment did not affect the staining intensity of their supernate liver ALP. Biliary ALP, however, became undetectable in the supernates and the electrophoretograms showed marked staining at the origin, indicating that the biliary fraction was bound but not precipitated. The precipitates from such plasmas showed small amounts of liver and biliary isoenzyme. In the seven samples examined, this precipitated ALP activity averaged 17% of total ALP. Pretreatment of these samples by incubation with Triton X-100 eliminated the biliary band in the electrophoretograms of the supernates and enhanced liver ALP activity, which suggests conversion of biliary to liver-type ALP by delipidation (7) . Electrophoresis of the precipitates showed only a minimal amount of the liver isoenzyme and no biliary ALP, so that the precipitated ALP activity now averaged only 12% of total ALP activity.
We did not detect intestinal ALP in precipitates from samples containing this fraction; it remained in the supernates. Because both the sequential heat-inactivation and the lectin precipitation include both intestinal and biliary ALP in the liver fraction, we applied no correction to the precipitation method to compensate for their presence. Intestinal ALP was detectable by electrophoresis in only six of 74 (8.1%) samples from patients with bone or liver disease and in only 11 of the 67 healthy subjects (16.4%). In the former group the activity of intestinal ALP did not exceed 12% (mean 8.3%) of total ALP or 43 U/L (mean 28 U/L). In the latter group, intestinal ALP activity did not exceed 37 U/L (mean 19 U/L). Biliary ALP was present in 41 patients' samples (mean ± SD 164 ± 127 U/L, representing 28 ± 13% of total ALP activity).
Linearity: The correlation of bone and liver ALP activities by lectin precipitation and by heat-inactivation was linear for total ALP activity up to at least 15-fold the adult upper reference limit, and up to 3000 U/L for bone ALP or 1000 UfL for liver ALP. Diluting the high-activity samples in water, saline, or heated plasma impaired the precipitation of bone phosphatase and is not recommended. For samples containing total ALP activity greater than 3000 U/L, the concentration of lectin in the precipitating solution should be proportionately increased.
Reference 
Affinity Electrophoresis
In plasma samples containing both bone and liver ALP, the bone isoenzyme had retarded mobility and was clearly separated from the liver enzyme by the new procedure, whereas with the unmodified conventional method the two fractions were incompletely resolved (Figure 1) . Biliary ALP, when present, was bound by the lectin and either remained at or near the origin, in contrast to its a1-globulin mobility, anodal to the liver and bone fractions, by conventional electrophoresis. The mobility of intestinal ALP (normally cathodal to bone ALP) was unaffected.Similar patternswere obtained with either plasma or serum from the same blood sample, although the resolution was bestwhen we used fresh serum. Repeated freezingand thawing impaired the quality of separation.
Optimization studies:
Using various concentrations of wheat-germ lectin (between 0.025 and 0.1 g/L) in buffer, we determined that a 50 mg/L concentration best resolved the bone and liver isoenzymes.
Comparison studies: Resolution between the bone and liver fractions by the lectin procedure was such that we could quantify them by densitometry, which we used to compare ALP isoenzyme activity by the new electrophoretic method (y) with that determined by wheat germ lectin precipitation and by sequential heat-inactivation. 
Linearity: The correlation of bone and liver ALP activities by lectin affinity electrophoresis and by lectin precipitation was linear over the same range as that stated above for the lectin precipitation procedure.
Precision: We determined the within-batch and betweenbatch precision of the method with a plasma sample having total ALP activity of 220 U/L.The within-batch (n = 16) CV was 1.2% at a mean liver ALP activity of 161 UIL and 3.2% at a mean bone ALP activity of 59 UIL. The corresponding between-batch (n = 24) CVs were 2.2% and 5.1%, respective- 
DIscussion
Alkaline phosphatase is present in tissue-specific ("isoenzyme") forms in liver, bone, intestine, and placenta. In health, plasma ALP originates principally from bone and liver, with a minor contribution (averaging 10% of total activity) from the intestine in approximately one-quarter of all subjects (9). In the latter half of pregnancy, ALP of placental origin may enter plasma.
Measurement of plasma ALP is of established diagnostic value in bone and liver disease. These disorders increase plasma totalALP as a result of increased entry into the plasma of the bone or liver ALP isoenzymes.In addition, in liver disease, biliary ALP (synonyms: high molecular mass ALP; alpha1 ALP; "fast" ALP) derived from cells lining the biliary tract or from the aggregation in bile or plasma of liver ALP with lipid or protein may appear in plasma (7,10), and plasma intestinal ALP activity may increase as a result of decreased hepatic uptake of this fraction (11) .
Approximately half of the clinical requests for ALP isoenzyme determinations are for the differentiation of a bone or liver source for an above-normal activity of totalALP (9). For thispurpose, qualitative identification of the isoenzyme composition of plasma is adequate. However, particularly when total ALP activity is within the normal range, quantitative rather than qualitative measurement of bone and liver phosphatase increases the sensitivity of isoenzyme analysis, by permitting detection of minor changes in the activities of these isoenzymes. Quantitative measurements are also essential for the serial monitoring of the activity of these fractions, which is especially required in the follow-up of patients with malignant disease, to identify bone or liver metastases and the response of these to therapy.
Although electrophoresis is convenient for qualitative examination of ALP isoenzymes, bone and liver phosphatasesare generally insufficiently resolved by electrophoresis to permit their quantification by densitometry, even though thismay be suitable for measuring biliary and intestinal ALP activities.
Of the various nonelectrophoretic methods for quantifying bone and liver ALP activity in plasma (12), most involve use of minor differences in the response of bone and liver ALP to heat or to inhibitors. However, these procedures have proved too complex, insensitive, or unreliable for clinical application; only the use of sequential heat-inactivation has gained any degree of acceptance. We find that this procedure is too tedious and impractical for large sample numbers and that it requires scrupulous procedural control for even moderate reproducibility. In contrast, the precipitation and affinity electrophoresis methods with wheat-germ lectin are very reproducible, give excellent resolution of the bone and liver isoenzymes, readily permit their quantification, and can be carried out in any diagnostic biochemistry laboratory. Because wheat-germ lectin is known to bind to N-acetylglucosamine residues of glycoproteins (6), the differential effects of the lectin presumably reflect differences in the surface carbohydrates of the bone and liver isoenzymes.
With our precipitation method, a preliminary conventional electrophoresis of ALP isoenzymes is desirable, to identify and quantify the biliary isoenzyme, if present, and to permit quantification of any intestinal ALP, which otherwise would be included with the liver fraction. Note that preliminary electrophoresis is also recommended for the comparison heat-inactivation procedure and for most other non-electrophoretic procedures and that the heat-inactivation method also includes biliary and intestinal ALP with the liver fraction. Biliary ALP is itself of hepatobiliary origin; except in liver cirrhosis, activity of intestinal ALP in plasma is generally too low to significantly interfere and may be further reduced in samples from fasting patients. Nevertheless, separate quantification of these fractions may be of diagnostic value.
When biliary ALP is present, preincubation of the sample with Triton X-100 prevents the precipitation of biliary ALP without affecting the differentiation between the bone and liver isoenzymes.Without such pretreatment, about onequarter of the biliary ALP would be precipitated and measured with the bone fraction. If samples do not undergo preliminary electrophoresis before precipitation withwheatgerm lectin, allsamples should be pretreated with Triton X-100.
As an alternative to the precipitation procedure, modification of conventional electrophoresis by including wheatgerm lectin in the buffer for soaking the cellulose acetate membrane improves the resolution of the bone and liver ALP fractions. In the absence of such modification the two fractions overlap and cannot be quantified. The mobility of intestinal ALP is unaltered, but biliary ALP, which is of a1 mobility by conventional electrophoresis, is markedly retarded and remains at or near the origin. Occasionally one sees faint, diffuse staining between the origin and bone fraction. Consequently, where quantification of biliary or intestinal phosphatase is required, we recommend parallel separation of samples by modified and unmodified electrophoresis.
In conclusion, after treatment with wheat-germ lectin, measurement of ALP activity in the precipitate can be used to quantify bone phosphatase and, by the difference from totalALP, the amount of liver isoenzyme in plasma. The precipitation procedure is preferably preceded by isoenzyme electrophoresis, which can correct the activity of the liver fraction for biliary or intestinal isoenzyme therein. In pregnant subjects, heat treatment of the plasma can correct for placental phosphatase, which otherwise would be included in the liver fraction. Although the precipitation method is the more convenient if quantification of bone ALP alone is required, the affinity electrophoresis procedure improves the electrophoretic resolution of bone and liver ALP such that each can be quantified by densitometry, thus permitting quantification of bone, liver, biliary, and intestinal ALP fractions by electrophoresis alone.
